These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2040191)

  • 21. A randomized, placebo-controlled clinical trial of recombinant human erythropoietin in the anemia of prematurity.
    Mentzer WC; Shannon KM; Abels RI; Freeman P; Newton N; Thompson D; Phibbs RH
    Contrib Nephrol; 1991; 88():306-12; discussion 313. PubMed ID: 2040193
    [No Abstract]   [Full Text] [Related]  

  • 22. Growth factors and HIV-infection in children.
    Zuccotti GV; Flumine P; Locatelli V; Banderali G; Riva E
    J Int Med Res; 1993; 21(6):342-5. PubMed ID: 7511543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anaphylactic reaction to recombinant human erythropoietin.
    García JE; Senent C; Pascual C; Fernandez G; Perez-Carral C; Diaz-Tejeiro R; Gomez E; Sierra T
    Nephron; 1993; 65(4):636-7. PubMed ID: 8302424
    [No Abstract]   [Full Text] [Related]  

  • 24. Changes in determinants of blood rheology during treatment with haemodialysis and recombinant human erythropoietin.
    Koppensteiner R; Stockenhuber F; Jahn C; Balcke P; Minar E; Ehringer H
    BMJ; 1990 Jun; 300(6740):1626-7. PubMed ID: 2372642
    [No Abstract]   [Full Text] [Related]  

  • 25. Guidelines for the use of recombinant human erythropoietin.
    Barosi G; Cazzola M; De Vincentiis A; Grossi A; Tura S
    Haematologica; 1994; 79(6):526-33. PubMed ID: 7896210
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
    Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
    Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythropoietin.
    Haberl M
    Aust Nurses J; 1990 Sep; 20(2):29. PubMed ID: 2268202
    [No Abstract]   [Full Text] [Related]  

  • 28. [Recombinant human erythropoietin and chronic kidney failure: current situation and therapeutic implications].
    Romero González R; Torquet Escuder P
    Med Clin (Barc); 1990 Nov; 95(17):656-9. PubMed ID: 2089205
    [No Abstract]   [Full Text] [Related]  

  • 29. Cytokine biology. Implications for transfusion medicine.
    Adamson JW
    Cancer; 1991 May; 67(10 Suppl):2708-11. PubMed ID: 2015573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of the anemia of multiple myeloma: the role of recombinant human erythropoietin.
    Barlogie B
    Semin Hematol; 1993 Oct; 30(4 Suppl 6):25-7. PubMed ID: 8153675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficiency of recombinant human erythropoietin treatment in anemic pregnant women with a kidney transplant.
    Szurkowski M; Wiecek A; Kokot F; Daniel K
    Nephron; 1994; 67(2):242-3. PubMed ID: 8072619
    [No Abstract]   [Full Text] [Related]  

  • 32. Recombinant human erythropoietin for patients with AIDS treated with zidovudine.
    Fischl M; Galpin JE; Levine JD; Groopman JE; Henry DH; Kennedy P; Miles S; Robbins W; Starrett B; Zalusky R
    N Engl J Med; 1990 May; 322(21):1488-93. PubMed ID: 2186273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human recombinant erythropoietin: progress in clinical development.
    Kubiak W; Karwacki M; Mazur I
    Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():39-50. PubMed ID: 8192531
    [No Abstract]   [Full Text] [Related]  

  • 34. Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial.
    Eschbach JW; Abdulhadi MH; Browne JK; Delano BG; Downing MR; Egrie JC; Evans RW; Friedman EA; Graber SE; Haley NR
    Ann Intern Med; 1989 Dec; 111(12):992-1000. PubMed ID: 2688507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A multicenter trial of Recormon within the framework of international controlled research].
    Tareeva IE; Nikolaev AIu; Klepikov PV; Lashutin SV; Riabov SI; Shostka GD; Ermolenko VM; Rozental' RL; Vorob'ev PA; Miagkov AV
    Ter Arkh; 1992; 64(8):59-62. PubMed ID: 1440400
    [No Abstract]   [Full Text] [Related]  

  • 36. Recombinant human erythropoietin for a Jehovah's Witness with anemia of thermal injury.
    Boshkov LK; Tredget EE; Janowska-Wieczorek A
    Am J Hematol; 1991 May; 37(1):53-4. PubMed ID: 2024641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of rHuEPO in treatment of uremic anemia prior to end-stage renal disease.
    Koene RA; Frenken LA
    Kidney Int Suppl; 1992 Oct; 38():S142-7. PubMed ID: 1405365
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical application of recombinant erythropoietin in anemic cancer patients.
    Henry DH
    Hematol Oncol Clin North Am; 1994 Oct; 8(5):961-73. PubMed ID: 7852218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant human erythropoietin at high dose is effective for the treatment of the anemia of myelodysplastic syndromes.
    Laporte JP; Isnard F; Fenaux P; Woler M; Najman A
    Contrib Nephrol; 1991; 88():271-2; discussion 273-5. PubMed ID: 2040189
    [No Abstract]   [Full Text] [Related]  

  • 40. Changes in the alpha adrenergic system and increase in blood pressure with recombinant human erythropoietin (rHuEpo) therapy for renal anemia.
    Müller R; Steffen HM; Brunner R; Saric J; Pollok M; Baldamus CA; Kaufmann W
    Clin Invest Med; 1991 Dec; 14(6):614-22. PubMed ID: 1665406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.